New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareGHK-Cu vs Eloralintide

GHK-Cu vs Eloralintide

Side-by-side comparison of key properties, dosing, and research.

Skin & CosmeticRecovery & RepairAnti-Aging & Longevity
GHK-Cu
GLP-1 / Weight Loss Agonists
Eloralintide
Summary
GHK-Cu is a naturally occurring copper complex that declines with age. It is one of the most studied anti-aging peptides, known for powerful skin rejuvenation, wound healing, and tissue remodeling effects.
Eloralintide is a long-acting amylin analog under development by OPKO Health. Amylin is co-secreted with insulin and regulates post-meal glucose by slowing gastric emptying, suppressing glucagon, and promoting satiety. Eloralintide is designed for once-weekly dosing, differentiating it from the short-acting pramlintide (Symlin). It is being studied for obesity and type 2 diabetes as a complement to GLP-1 based therapies.
Half-Life
2–4 hours
~7 days (estimated, long-acting design)
Admin Route
SubQ, Topical
SubQ
Research
Typical Dose
1–3 mg
Under investigation in Phase 1/2 trials
Frequency
3–5 times per week
Once weekly
Key Benefits
  • Reduces wrinkles and fine lines
  • Improves skin firmness and elasticity
  • Accelerates wound healing
  • Reduces inflammation and oxidative damage
  • Promotes hair growth and thickness
  • Supports collagen and elastin production
  • May improve overall skin health and appearance
  • Resets aged fibroblast behavior
  • Anti-fibrotic — reduces scar tissue formation
  • Once-weekly dosing (vs multiple daily injections for pramlintide)
  • Appetite suppression via central amylin receptor activation
  • Reduction in post-meal glucagon secretion
  • Complementary mechanism to GLP-1 agonists for combination therapy
  • Slows gastric emptying for prolonged satiety
  • Potential additive weight loss when combined with GLP-1 agents
Side Effects
  • Temporary blue-green discoloration at injection site (from copper — harmless)
  • Post-injection sting (brief)
  • Skin irritation with topical use (rare)
  • Nausea
  • Vomiting
  • Decreased appetite
  • Injection site reactions
  • +1 more
Stacks With